TNSN86144A1 - Procede pour la preparation de derives de la flavone - Google Patents
Procede pour la preparation de derives de la flavoneInfo
- Publication number
- TNSN86144A1 TNSN86144A1 TNTNSN86144A TNSN86144A TNSN86144A1 TN SN86144 A1 TNSN86144 A1 TN SN86144A1 TN TNSN86144 A TNTNSN86144 A TN TNSN86144A TN SN86144 A TNSN86144 A TN SN86144A TN SN86144 A1 TNSN86144 A1 TN SN86144A1
- Authority
- TN
- Tunisia
- Prior art keywords
- carbon atoms
- alkyl
- different
- phenyl
- general formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
PROCEDE POUR LA PREPARTION DE NOUVEAUX DERIVES DE LA FLAVONE DE FORMULE GENERALE (I) DANS LESQUELS R ET R1 PEUVENT ETRE EGAUX OU DIFFERENTS ET SONT UN ALKYLE CONTENANT 1 A 4 ATOMES DE CARBONE, HYDROXY ALKYLE CONTENANT 1 A 4 ATOMES DE CARBONE, FORMYLALKYLE OU CYANOALKYLE, R2 ET R3 PEUVENT ETRE EGAUX OU DIFFERENTS ET SONT UN ALKYLE LINEAIRE OU RAMIFIE CONTENANT 1 A 6 ATOMES DE CARBONE, ALKENYLE LINEAIRE OU RAMIFIE CONTENANT 2 A 6 ATOMES DE CARBONE, ALKYNYLE CONTENANT 2 A 6 ATOMES DE CARBONE, CYCLOALKYLE AYANT 5 A 7 ATOMES DE CARBONE, ARALKYLE, PHENYLE, CYANOALKYLE, HALOALKYLE, MONO- OU POLY- HYDROXYALKYLE, ALKOXYALKYLE, ALKYLTHIOALKYLE, ALKYLSULFONYLALKYLE, ACYLOXYALKYLE, ACYLALKYLE, R4R5N-ALKYLE LINEAIRE OU RAMIFIE AYANT 2 A 6 ATOMES DE CARBONE, OU R4 ET R5 SONT EGAUX OU DIFFERENTS ET SONT HYDROGENE, ALKYLE, CYCLOALKYLE, ARALKYLE, PHENYLE, 3,3- DIPHENYLPROPYLE, OU EN ALTERNATIVE, ENSEMBLE AVEC L'ATOME D'HYROGENE, ILS FORMENT UNE CHAINE DE 4 A 7 ELEMENTS SATUREE OU NON SATUREE, CONTENANT D'AUTRES HETEROATOMES TELS QUE O, N OU LE GROUPE NR6 OU R6 EST UN ALKYLE, LEURS ISOMERES OPTIQUES ET DIASTEREOISOMERES, ET LEURS SELS PHARMACEUTIQUEMENT ACCEPTABLES. LES COMPOSES DE FORMULE GENERALE (I) MONTRENT UNE ACTIVITE CALCIUM-ANTAGONISTE ET/OU UNE ACTIVITE DE RELACHEMENT SUR LA MUSCULATURE LISSE (NOTAMMENT SUR LA VESSIE)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT22578/85A IT1190405B (it) | 1985-10-22 | 1985-10-22 | Derivati del flavone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TNSN86144A1 true TNSN86144A1 (fr) | 1990-01-01 |
Family
ID=11198039
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNTNSN86144A TNSN86144A1 (fr) | 1985-10-22 | 1986-10-21 | Procede pour la preparation de derives de la flavone |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US4806534A (fr) |
| EP (1) | EP0223744B1 (fr) |
| JP (1) | JPH0772186B2 (fr) |
| KR (1) | KR910009269B1 (fr) |
| CN (1) | CN86107544A (fr) |
| AR (1) | AR243883A1 (fr) |
| AT (1) | ATE73453T1 (fr) |
| AU (1) | AU596382B2 (fr) |
| CA (1) | CA1330994C (fr) |
| DE (1) | DE3684244D1 (fr) |
| DK (1) | DK169408B1 (fr) |
| EG (1) | EG18109A (fr) |
| ES (1) | ES2002425A6 (fr) |
| FI (1) | FI89167C (fr) |
| GR (1) | GR862546B (fr) |
| HU (1) | HU202863B (fr) |
| IE (1) | IE58330B1 (fr) |
| IL (1) | IL80229A0 (fr) |
| IT (1) | IT1190405B (fr) |
| NO (1) | NO167570C (fr) |
| NZ (1) | NZ217964A (fr) |
| PH (1) | PH22766A (fr) |
| PT (1) | PT83604B (fr) |
| SG (1) | SG55192G (fr) |
| TN (1) | TNSN86144A1 (fr) |
| ZA (1) | ZA867941B (fr) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4912223A (en) * | 1988-01-28 | 1990-03-27 | Nelson Research & Development Co. | 1,4-Dihydropyridines |
| US5580751A (en) * | 1990-09-14 | 1996-12-03 | Carlsberg A/S | Process for the preparation of C-terminally amidated peptides |
| US5244602A (en) * | 1990-12-03 | 1993-09-14 | Ppg Industries, Inc. | Photochromic naphthopyrans |
| DE4321030A1 (de) * | 1993-06-24 | 1995-01-05 | Bayer Ag | 4-bicyclisch substituierte Dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimittel |
| SE9703377D0 (sv) * | 1997-09-18 | 1997-09-18 | Astra Ab | New compounds |
| KR100392468B1 (ko) * | 2000-09-18 | 2003-07-22 | 주식회사 엘지생명과학 | 사이클린 의존 키나아제의 저해제로서 유용한3-히드록시크로멘-4-온 유도체 |
| BR0206512A (pt) | 2001-01-16 | 2004-01-06 | Astrazeneca Ab | Composto, método de tratamento de um ser humano ou animal que sofre de depressão, ansiedade generalizada, distúrbios da alimentação, demência, distúrbio do p nico, distúrbios do sono, distúrbios gastrointestinais, distúrbios motores, distúrbios endócrinos, vasoespasmo e disfunção sexual, uso de um composto, e, processo para preparar um composto. |
| DE102005034264A1 (de) * | 2005-07-22 | 2007-02-01 | Bayer Healthcare Ag | 4-Chromenonyl-1,4-dihydropyridincarbonitrile und ihre Verwendung |
| DE102005034267A1 (de) * | 2005-07-22 | 2007-01-25 | Bayer Healthcare Ag | 4-Chromenonyl-1,4-dihydropyridine und ihre Verwendung |
| CN103254122B (zh) * | 2013-06-19 | 2015-04-22 | 湖南师范大学 | 一种心血管药物尼伐地平的制备方法 |
| AR121719A1 (es) | 2020-04-03 | 2022-06-29 | Petra Pharma Corp | Inhibidores alostéricos de cromenona del fosfoinosítido 3-quinasa (pi3k) para el tratamiento de enfermedades |
| MX2023013080A (es) | 2021-05-03 | 2023-11-16 | Petra Pharma Corp | Inhibidores alostericos de cromenona del fosfoinositido 3-quinasa (pi3k) para el tratamiento de enfermedades. |
| WO2022251482A1 (fr) | 2021-05-27 | 2022-12-01 | Petra Pharma Corporation | Inhibiteurs chroménone allostériques de la phosphoinositide 3-kinase (pi3k) pour le traitement du cancer |
| TW202329930A (zh) | 2021-09-30 | 2023-08-01 | 美商佩特拉製藥公司 | 用於治療疾病之磷酸肌醇3-激酶(pi3k)之異位色烯酮抑制劑 |
| CN115536644B (zh) * | 2022-09-27 | 2024-09-03 | 广西民族大学 | 一种色酮-2-甲酰胺类化合物用于制备降血糖药物的用途及其制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2921070A (en) * | 1957-11-05 | 1960-01-12 | Recordati Lab Farmacologico S | Basic esters of 3-methylflavone-8-carboxylic acid |
| NZ201395A (en) * | 1981-07-30 | 1987-02-20 | Bayer Ag | Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines |
| DE3311005A1 (de) * | 1983-03-25 | 1984-09-27 | Bayer Ag, 5090 Leverkusen | Chromon- und thiochromonsubstituierte 1,4-dihydropyridinderivate, mehrere verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln |
-
1985
- 1985-10-22 IT IT22578/85A patent/IT1190405B/it active
-
1986
- 1986-10-03 IL IL80229A patent/IL80229A0/xx not_active IP Right Cessation
- 1986-10-14 GR GR862546A patent/GR862546B/el unknown
- 1986-10-15 AR AR86305576A patent/AR243883A1/es active
- 1986-10-15 NO NO864108A patent/NO167570C/no unknown
- 1986-10-16 NZ NZ217964A patent/NZ217964A/en unknown
- 1986-10-20 EP EP86830300A patent/EP0223744B1/fr not_active Expired - Lifetime
- 1986-10-20 DE DE8686830300T patent/DE3684244D1/de not_active Expired - Fee Related
- 1986-10-20 ES ES8602677A patent/ES2002425A6/es not_active Expired
- 1986-10-20 ZA ZA867941A patent/ZA867941B/xx unknown
- 1986-10-20 AT AT86830300T patent/ATE73453T1/de not_active IP Right Cessation
- 1986-10-21 TN TNTNSN86144A patent/TNSN86144A1/fr unknown
- 1986-10-21 HU HU864363A patent/HU202863B/hu not_active IP Right Cessation
- 1986-10-21 FI FI864260A patent/FI89167C/fi not_active IP Right Cessation
- 1986-10-21 IE IE276886A patent/IE58330B1/en not_active IP Right Cessation
- 1986-10-21 JP JP61251553A patent/JPH0772186B2/ja not_active Expired - Lifetime
- 1986-10-21 CA CA000520953A patent/CA1330994C/fr not_active Expired - Fee Related
- 1986-10-22 AU AU64273/86A patent/AU596382B2/en not_active Ceased
- 1986-10-22 KR KR1019860008836A patent/KR910009269B1/ko not_active Expired
- 1986-10-22 US US06/921,397 patent/US4806534A/en not_active Expired - Fee Related
- 1986-10-22 PT PT83604A patent/PT83604B/pt not_active IP Right Cessation
- 1986-10-22 CN CN198686107544A patent/CN86107544A/zh active Pending
- 1986-10-22 EG EG662/86A patent/EG18109A/xx active
- 1986-10-22 PH PH34400A patent/PH22766A/en unknown
- 1986-10-22 DK DK506386A patent/DK169408B1/da not_active IP Right Cessation
-
1992
- 1992-05-23 SG SG551/92A patent/SG55192G/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TNSN86144A1 (fr) | Procede pour la preparation de derives de la flavone | |
| TNSN86111A1 (fr) | Procede de preparation d'hydroxyalkylxanthines tertiaires | |
| FR2603588A1 (fr) | Thiazolo (4,5-c) quinoleines, procede de preparation et medicaments les contenant | |
| FR2453854A1 (fr) | Nouveaux derives d'o-(4-diphenylmethylpiperidino)-1-phenylalcanols, utiles notamment comme antihistaminiques, et leur procede de preparation | |
| NL990025I1 (nl) | Sulfamaatderivaten met anticonvulsieve werking. | |
| OA09482A (fr) | "Nouveaux dérivés à structure naphtalénique, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent". | |
| BG50939A3 (bg) | Метод за получаване на пиридазинонови производни | |
| NO860852L (no) | Tilling derav. | |
| BE905110A (fr) | Poly-4-aminopyrrole-2-carboxamides et derives, procede pour leur preparation et leurs utilisations therapeutiques. | |
| FR2401913A1 (fr) | Nouveaux 3-(2-hydroxy-4(substituant)-phenyl)-azacycloalcanes et medicament les contenant | |
| FR2448531A1 (fr) | Nouveaux derives de 4-(naphtylmethyl)piperidine, utiles notamment comme agents antipsychotiques et leur procede de preparation | |
| BE903846A (fr) | Composes derives d'indole, compositions pharmaceutiques les contenant et procede pour leur preparation. | |
| FR2408584A1 (fr) | Composes guanidinobenzoiques et possedant une activite antifibrinolysine et antitrypsine et leur procede de preparation | |
| BE1002868A4 (fr) | Derives d'acylphenols. | |
| ATE41772T1 (de) | Polymethoxybenzyl-piperazin-derivate, verfahren zu ihrer herstellung und diese derivate enthaltende pharmazeutische zusammensetzungen. | |
| FR2452483A1 (fr) | Derives d'alcenylphenylmaleimides, leurs dimeres lineaires et leur procede de preparation | |
| ES2004141A6 (es) | Un procedimiento de preparacion de nuevas 1,4-dihidropiridinas | |
| FR2438048A1 (fr) | Nouveaux derives de 1,3-oxazino (5,6-c) rifamycine doues d'une activite antibiotique | |
| FR2411173A1 (fr) | Anthranilates de n-hydroxyalkyl-carboxamides et leur application comme reticulants | |
| TNSN91055A1 (fr) | Nouvelles tetrahydroimidazo (1,4) benzodiazepine -2-(thi) ones | |
| BE900607A (fr) | Agents prophylactiques et medicaments anti-adhesifs contenant un derive de benzylamine ayant une action secretolytique. | |
| ES8604121A1 (es) | Procedimiento para la preparacion de esteres de acido guani-dinobenzoico | |
| KR950702566A (ko) | 사슬형 아미딘기를 포함하는 디포스폰산 유도체, 그것의 제조방법 및 그것을 포함하는 의약 조성물(novel acyclic amidine-group-containing diphosphonic acid derivatives, process for producing them and medicaments containing these compounds) | |
| TNSN86139A1 (fr) | Procede pour l'obtention de derives aromatiques substitues par un groupement (omega amino) alcanol a activite antimicrobienne | |
| FR2603589A1 (fr) | Compose (phenyldimethylcarbinyl)-silane et son procede de preparation |